| ID | 65154 |
| JaLCDOI | |
| フルテキストURL | |
| 著者 |
Iriyoshi, Hiroki
Department of Internal Medicine, Kochi Prefectural Hata-Kenmin Hospital
Sada, Ken-ei
Department of Internal Medicine, Kochi Prefectural Hata-Kenmin Hospital
Miyauchi, Atsushi
Department of Internal Medicine, Kochi Prefectural Hata-Kenmin Hospital
Yamamoto, Hirotaka
Department of Internal Medicine, Kochi Prefectural Hata-Kenmin Hospital
Hashimoto, Daisuke
Department of Internal Medicine, Kochi Prefectural Hata-Kenmin Hospital
Nojima, Shigeru
Department of Internal Medicine, Kochi Prefectural Hata-Kenmin Hospital
Yamanaka, Shingo
Department of Internal Medicine, Kochi Prefectural Hata-Kenmin Hospital
Kawamura, Masafumi
Department of Internal Medicine, Kochi Prefectural Hata-Kenmin Hospital
Oka, Satoshi
Department of Internal Medicine, Kochi Prefectural Hata-Kenmin Hospital
|
| 抄録 | Several previous case reports have shown that patients with immunoglobulin D (IgD) multiple myeloma (MM) can be withdrawn from hemodialysis, however, the characteristics that can predict withdrawal in these patients have not yet been elucidated. A 57-year-old Japanese woman required hemodialysis because of renal dysfunction due to IgD-λ and Bence Jones protein-λ MM. Bortezomib-based chemotherapy nine days after admission led to her withdrawal from hemodialysis on Day 50. In our case-based review, younger age and early initiation of bortezomib-based chemotherapy emerged as possible predictors of successful hemodialysis withdrawal.
|
| キーワード | IgD-type multiple myeloma
acute renal dysfunction
urinary protein
hemodialysis
bortezomib
|
| Amo Type | Case Report
|
| 出版物タイトル |
Acta Medica Okayama
|
| 発行日 | 2023-04
|
| 巻 | 77巻
|
| 号 | 2号
|
| 出版者 | Okayama University Medical School
|
| 開始ページ | 221
|
| 終了ページ | 225
|
| ISSN | 0386-300X
|
| NCID | AA00508441
|
| 資料タイプ |
学術雑誌論文
|
| 言語 |
英語
|
| 著作権者 | Copyright Ⓒ 2023 by Okayama University Medical School
|
| 論文のバージョン | publisher
|
| 査読 |
有り
|
| PubMed ID | |
| Web of Science KeyUT |
